Discreet, evidence-based care for Alaska women — HSDD, perimenopause, menopausal hormone therapy, low-dose testosterone for women, and vaginal estrogen — delivered by clinicians licensed in Alaska.
OmniRx Health providers are licensed by the Alaska State Medical Board to deliver telehealth services across the entire state, from Anchorage to remote bush communities.
Hypoactive sexual desire disorder affects about 1 in 10 adult women. Treatable with FDA-approved Addyi or Vyleesi, low-dose testosterone, and addressing modifiable contributors like SSRIs and contraceptive choice.
Modern menopausal hormone therapy — typically transdermal estradiol with cyclic or continuous progesterone — for hot flashes, sleep disruption, libido changes, and mood symptoms.
Local vaginal estrogen, DHEA inserts (prasterone), and ospemifene for genitourinary symptoms with very low systemic absorption.
Off-label and supported by international guidelines for postmenopausal HSDD. Carefully titrated based on baseline labs, with quarterly monitoring.
Alaska has long embraced telehealth out of necessity, with state laws supporting comprehensive virtual care delivery including audio-only visits for areas with limited broadband.
We partner with Alaska-licensed pharmacies in Anchorage, Fairbanks, and Juneau, with shipping logistics designed to reach communities throughout the Last Frontier.
Visits, intake forms, and lab results are protected health information. Medication ships in plain, unmarked packaging anywhere in Alaska. If you choose cash-pay, no insurance EOB is sent to your household.